Status:
COMPLETED
Physician's Evaluation of Cyclosporine Ophthalmic Emulsion 0.05%
Lead Sponsor:
Allergan
Conditions:
Dry Eye Disease
Eligibility:
All Genders
16+ years
Brief Summary
The objective of this retrospective chart review is to evaluate the patient characteristics, treatment variations and efficacy of a second trial of Cyclosporine Ophthalmic Emulsion 0.05% therapy in ch...
Eligibility Criteria
Inclusion
- Adults \>16 years of age
- Dry eye patients
- Subject with history of less than 12 weeks of initial RESTASIS® treatment
- Subject started second trial of RESTASIS® treatment prior to June 1, 2008
- First day of second trial of RESTASIS® started ≥ 4 weeks after the last day of previous RESTASIS® treatment
Exclusion
- Patients with Contact Lens Intolerance
- Patients with Ocular Rosacea
Key Trial Info
Start Date :
January 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2009
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT00827255
Start Date
January 1 2009
End Date
October 1 2009
Last Update
April 25 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pittsburgh, Pennsylvania, United States